Gabelli Healthcare & WellnessRx Trust

GRXReported to SECin USCIK 0001391437Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 8. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 8
Form 4 lines at Gabelli Healthcare & WellnessRx Trust, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Saba Capital Management, L.P.—Open-market buy$4,941519 sharesOct 1, 2026Saba Capital Management, L.P.$4,941Buy · Oct 1Open-market buy519Oct 1, 2026
Saba Capital Management, L.P.—Open-market buy$3,884400 sharesSep 14, 2026Saba Capital Management, L.P.$3,884Buy · Sep 14Open-market buy400Sep 14, 2026
Saba Capital Management, L.P.—Open-market buy$5,040500 sharesSep 8, 2026Saba Capital Management, L.P.$5,040Buy · Sep 8Open-market buy500Sep 8, 2026
Saba Capital Management, L.P.—Open-market buy$43,6174,340 sharesAug 28, 2026Saba Capital Management, L.P.$43,617Buy · Aug 28Open-market buy4,340Aug 28, 2026
Saba Capital Management, L.P.—Open-market buy$71,7917,087 sharesAug 24, 2026Saba Capital Management, L.P.$71,791Buy · Aug 24Open-market buy7,087Aug 24, 2026